http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2379312-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0731561a52d2a421a6be8d43f150de89 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate | 2004-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e588faf2a9ac82bfcadcf3bba9e4429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da427d862949560d4d28f4a15da4f7f0 |
| publicationDate | 2010-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2379312-C2 |
| titleOfInvention | Lysine compounds, pharmaceutical composition containing these compounds, application of said compounds for treatment or prevention of hiv-infection |
| abstract | FIELD: medicine. n SUBSTANCE: present invention concerns lysine compounds of formula (I) or its pharmaceutically acceptable salts, a based pharmaceutical compositions and application for treatment or prevention of HIV-infection. The compounds of formula (I) where n is equal to 3 or 4, where X and Y identical or different are chosen from the group consisting of H, F, Cl, Br, I and -NR 4 R 5 , where R 6 is chosen from the group consisting of unbranched alkyl group, containing 1 to 6 carbon atoms, and branched alkyl group containing 3 to 6 carbon atoms, where R 3 is chosen from the group consisting of the group of formula R 3A -CO-, and R 3a is chosen from the group consisting of unbranched or branched alkyl group containing 1 to 6 carbon atoms, alkyloxygroup containing 1 to 6 carbon atoms, and 4-morpholinyl, where R 4 and R 5 are identical and represent H, where R 2 is chosen from the group consisting of diphenylmethyl group, naphthyl-1-CH 2 -group, and naphthyl-2-CH 2 -group, where X' and Y' are identical and represent H, and where R 1 is chosen from the group consisting of from (HO) 2 P(O) and (MO) 2 P(O), where M represents alkaline metal. n EFFECT: lysine compounds representing effective inhibitors of aspartyl-protease. n 15 cl, 3 tbl, 1 ex |
| priorityDate | 2004-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 301.